ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
3 clinical trials · Sponsor
◉ Watch ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Phase Ⅰb/Ⅱa Clinical Study of IMC-003 Injection for the Treatment of Pulmonary Arterial Hypertension Receiving Background Therapy. (NCT07593027) | ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. | 2026-04-30 |
| A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus (NCT06535412) | ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. | 2024-10-10 |
| A Study to Evaluate IMC-002 in Neuromyelitis Optica Spectrum Disorder (NMOSD) Patients (NCT06557174) | ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. | 2024-10-10 |
Track ImmuneCare Biopharmaceuticals (Shanghai) Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.